Establishment Labs Holdings Inc.
$66.93
▼
-0.66%
2026-04-21 06:42:01
www.establishmentlabs.com
NCM: ESTA
Explore Establishment Labs Holdings Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.96 B
Current Price
$66.93
52W High / Low
$83.31 / $28.67
Stock P/E
—
Book Value
$0.8
Dividend Yield
—
ROCE
-14.18%
ROE
-1.33%
Face Value
—
EPS
$-1.72
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
1,004
Beta
1.08
Debt / Equity
1,123.14
Current Ratio
3.04
Quick Ratio
2
Forward P/E
293.61
Price / Sales
8.36
Enterprise Value
$1.95 B
EV / EBITDA
-66.35
EV / Revenue
9.26
Rating
Strong Buy
Target Price
$88
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | WORK Medical Technology Group LTD | $1.2 | — | $1.6 M | — | -4.23% | -6.45% | $10,800 / $1.05 | $17.7 |
| 2. | Artivion, Inc. | $38.8 | 193.48 | $1.89 B | — | 3.41% | 2.7% | $48.25 / $22.22 | $9.37 |
| 3. | Envoy Medical, Inc. | $0.7 | — | $54.48 M | 3.34% | 741.34% | 155.22% | $1.91 / $0.36 | $-0.41 |
| 4. | Masimo Corporation | $178.4 | 46.03 | $9.34 B | — | 23.57% | 23.43% | $179 / $125.94 | $13.84 |
| 5. | enVVeno Medical Corporation | $12.08 | — | $7.92 M | — | -76.16% | -56.21% | $196.7 / $8.67 | $41.36 |
| 6. | Stryker Corporation | $334.05 | 39.78 | $127.84 B | 1.04% | 12.63% | 15.08% | $404.87 / $319.32 | $58.61 |
| 7. | Modular Medical, Inc. | $5.41 | — | $27.31 M | — | -109.03% | -3.32% | $34.5 / $3.55 | $2.27 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 64.62 M | 53.78 M | 51.3 M | 41.38 M | 44.51 M |
| Operating Profit | -3.93 M | -4.03 M | -14.11 M | -16.95 M | -18.67 M |
| Net Profit | -2.62 M | -11.15 M | -16.59 M | -20.71 M | -34.53 M |
| EPS in Rs | -0.09 | -0.38 | -0.57 | -0.71 | -1.18 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 211.08 M | 166.03 M | 165.15 M | 161.7 M |
| Operating Profit | -39.01 M | -49.99 M | -65.03 M | -39.66 M |
| Net Profit | -51.06 M | -84.6 M | -78.5 M | -75.21 M |
| EPS in Rs | -1.74 | -2.89 | -2.68 | -2.57 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 357.17 M | 346.83 M | 268.64 M | 211.06 M |
| Total Liabilities | 333.62 M | 293.74 M | 250.25 M | 219.25 M |
| Equity | 23.55 M | 53.09 M | 18.39 M | -8.19 M |
| Current Assets | 249.94 M | 243.04 M | 174.9 M | 149.9 M |
| Current Liabilities | 82.14 M | 68.28 M | 57.15 M | 38.96 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -50.89 M | -58.52 M | -88.51 M | -52.17 M |
| Investing CF | -7.03 M | -15.61 M | -24.55 M | -34.79 M |
| Financing CF | 40.43 M | 125.89 M | 86.23 M | 100.25 M |
| Free CF | -57.61 M | -74.08 M | -113.06 M | -86.43 M |
| Capex | -6.72 M | -15.56 M | -24.55 M | -34.27 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.53% | 2.13% | — | — |
| Earnings Growth % | -7.76% | -4.38% | — | — |
| Profit Margin % | -50.95% | -47.53% | -46.51% | — |
| Operating Margin % | -30.11% | -39.37% | -24.53% | — |
| Gross Margin % | 65.97% | 64.78% | 65.92% | — |
| EBITDA Margin % | -33.86% | -35.31% | -35.08% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.